Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Option Award(A) | 2024-03-20 7:42 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 213,486 | $0 | 213,486 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-20 7:41 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Bach Mark Allen CHIEF MEDICAL OFFICER | 65,352 | $0 | 65,352 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-20 7:39 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 91,494 | $0 | 91,494 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-20 7:37 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Yoon Jun CHIEF FINANCIAL OFFICER | 148,134 | $0 | 148,134 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-20 7:34 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Stevens Raymond C CHIEF EXECUTIVE OFFICER | 335,481 | $0 | 335,481 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:51 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Lin Xichen CHIEF SCIENTIFIC OFFICER | 299,193 | $0 | 299,193 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:48 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 128,223 | $0 | 128,223 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:46 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Bach Mark Allen CHIEF MEDICAL OFFICER | 91,587 | $0 | 91,587 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:44 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Yoon Jun CHIEF FINANCIAL OFFICER | 207,603 | $0 | 2,825,853 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:36 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Stevens Raymond C CHIEF EXECUTIVE OFFICER | 470,163 | $0 | 3,088,413 (Direct) | View |
| 2023-12-22 Other | 2023-12-27 10:49 am | N/A N/A | Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 10% Owner | 25,410 | $0 | 2,175,267 (Indirect) | View |
Ownership | 2023-10-12 08:55 am | N/A N/A | Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 10% Owner | 0 | $0 | 5,554,887 (Indirect) | View |
| 2023-08-03 Other | 2023-08-04 5:37 pm | N/A 2032-01-19 | Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director | 822,000 | $7.97 | 1,179,122 (Direct) | View |
| 2023-08-03 Option Award | 2023-08-04 5:34 pm | N/A 2033-08-02 | Structure Therapeutics Inc. | GPCR | LOVE TED W Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-05-10 Other | 2023-05-12 8:00 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 7,410,518 | $0 | 19,994,977 (Direct) | View |
Ownership | 2023-02-13 8:05 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 12,584,459 (Direct) | View |
| 2023-02-07 Conversion | 2023-02-09 7:12 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director | 123,508 | $0 | 123,508 (Indirect) | View |
| 2023-02-07 Conversion | 2023-02-09 7:09 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Farid Ramy Director | 642,245 | $0 | 3,535,495 (Indirect) | View |
| 2023-02-07 Conversion | 2023-02-09 2:42 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FMR LLC See Remark 1 | 5,816,554 | $0 | 4,769,404 (Indirect) | View |
| 2023-02-07 Conversion | 2023-02-09 2:04 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FIL Ltd See Remark 1 | 6,473,761 | $0 | 624,239 (Indirect) | View |
| 2023-02-02 Option Award | 2023-02-06 4:47 pm | N/A 2033-02-01 | Structure Therapeutics Inc. | GPCR | Yoon Jun Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 4:45 pm | N/A 2033-02-01 | Structure Therapeutics Inc. | GPCR | Stevens Raymond C Chief Executive Officer | 1,600,000 | $0 | 1,600,000 (Direct) | View |
Ownership | 2023-02-02 6:34 pm | N/A 2032-12-18 | Structure Therapeutics Inc. | GPCR | Waldstreicher Joanne Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2023-02-02 6:30 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | FIL Ltd See Remark 1 10% Owner | 0 | $0 | 6,473,761 (Indirect) | View |
Ownership | 2023-02-02 6:29 pm | N/A 2032-12-18 | Structure Therapeutics Inc. | GPCR | DOBMEIER ERIC Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2023-02-02 6:26 pm | N/A 2032-05-11 | Structure Therapeutics Inc. | GPCR | TETLOW SHARON Director | 0 | $0 | 80,000 (Direct) | View |
Ownership | 2023-02-02 6:24 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Farid Ramy Director | 0 | $0 | 3,260,495 (Indirect) | View |
Ownership | 2023-02-02 6:23 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | WELCH DANIEL G Director | 0 | $0 | 1,302,630 (Indirect) | View |
Ownership | 2023-02-02 6:21 pm | N/A 2032-01-19 | Structure Therapeutics Inc. | GPCR | Ma Yingli Chief Technology Officer | 0 | $0 | 400,000 (Direct) | View |
Ownership | 2023-02-02 6:19 pm | N/A 2031-09-22 | Structure Therapeutics Inc. | GPCR | Jung Melita Sun Chief Business Officer | 0 | $0 | 465,290 (Direct) | View |